September 2023 Newsletter

Highlights:

  • Suprelorin® approved for use in male dogs in Canada

  • Updates on our Marking study

  • September webinar with researchers presenting on groundbreaking cat contraceptive study

  • Conferences where ACC&D will be speaking this Fall

Read Newsletter
Previous
Previous

November 2023 Newsletter

Next
Next

June 2023 Newsletter: published research brings us closer to a spay shot!